Protective effects of nitric oxide on hepatic steatosis induced by total parenteral nutrition in rats.
To investigate the effects of nitric oxide (NO) on hepatic steatosis induced by total parenteral nutrition (TPN) in rats. Thirty normal Wistar rats were randomly divided into five groups: group A, free access to food and water; group B, TPN; group C, TPN plus arginine; group D, TPN plus NG-nitro-L-arginine methyl ester (L-NAME, NO synthase inhibitor); group E, TPN plus arginine and L-NAME. At the seventh day, liver function tests were examined, lipid content, nitric oxide level, and nitric oxide synthase (NOS) activity were measured, and histology was examined. The hepatic lipid content [triglyceride (mmol/g tissue), cholesterol (mmol/g tissue)] in group B was increased compared with group A (39.3+/-2.4 and 13.1+/-1.1 vs 6.9+/-0.8 and 5.6+/-0.6) (P<0.05). It was higher in group D (50+/-6 and 14.1+/-1.7) than in group B (P<0.05), whereas lower in group C (18+/-4 and 7+/-3) than in group B (P<0.05). The activity and distribution of NOS in the liver were associated with the content and distribution of hepatic lipid. These results suggest that nitric oxide produced by the liver may protect hepatic steatosis induced by total parenteral nutrition in rats.